摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

R-7-[3-(1-amino-1-methylethyl)-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid | 107334-06-5

中文名称
——
中文别名
——
英文名称
R-7-[3-(1-amino-1-methylethyl)-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid
英文别名
7-(3-(1-Amino-1-methylethyl)-1-pyrrolidinyl)-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid;7-[3-(2-aminopropan-2-yl)pyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid
R-7-[3-(1-amino-1-methylethyl)-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid化学式
CAS
107334-06-5
化学式
C19H23FN4O3
mdl
——
分子量
374.415
InChiKey
WZGKUGHHTACDTE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.7
  • 重原子数:
    27
  • 可旋转键数:
    4
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.53
  • 拓扑面积:
    99.8
  • 氢给体数:
    2
  • 氢受体数:
    8

文献信息

  • NOVEL ANTIBACTERIAL AGENTS FOR THE TREATMENT OF GRAM POSITIVE INFECTIONS
    申请人:MetCalf, III Chester A.
    公开号:US20100184649A1
    公开(公告)日:2010-07-22
    The present invention relates to novel lipopeptide compounds, pharmaceutical compositions of these compounds and methods of using these compounds as antibacterial compounds. The compounds of the invention are particularly useful against a variety of bacteria, including resistant strains. The compounds are useful as antibacterial agents against Clostridium difficile.
    本发明涉及新型脂肽化合物,这些化合物的药物组合物以及使用这些化合物作为抗菌化合物的方法。本发明的化合物特别适用于对抗各种细菌,包括耐药菌株。这些化合物可用作抗Clostridium difficile的抗菌剂。
  • Novel Lipopeptides as Antibacterial Agents
    申请人:Hill Jason
    公开号:US20090011977A1
    公开(公告)日:2009-01-08
    The present invention relates to novel lipopeptide compounds. The invention also relates to pharmaceutical compositions of these compounds and methods of using these compounds as antibacterial compounds. The invention also relates to methods of producing these novel lipopeptide compounds and intermediates used in producing these compounds.
    本发明涉及新型脂肽化合物。本发明还涉及这些化合物的药物组合物以及将这些化合物用作抗菌化合物的方法。本发明还涉及生产这些新型脂肽化合物的方法以及用于生产这些化合物的中间体。
  • Novel antibacterial agents for the treatment of GRAM positive infections
    申请人:Cubist Pharmaceuticals, Inc.
    公开号:EP2674437A1
    公开(公告)日:2013-12-18
    The present invention relates to novel lipopeptide compounds, pharmaceutical compositions of these compounds and methods of using these compounds as antibacterial compounds. The compounds of the invention are particularly useful against a variety of bacteria, including resistant strains. The compounds are useful as antibacterial agents against Clostridium difficile.
    本发明涉及新型脂肽化合物、这些化合物的药物组合物以及将这些化合物用作抗菌化合物的方法。本发明的化合物特别适用于抗击各种细菌,包括耐药菌株。本发明化合物可用作抗艰难梭菌的抗菌剂。
  • Novel lipopeptides as antibacterial agents
    申请人:Hill Jason
    公开号:US20050203006A1
    公开(公告)日:2005-09-15
    The present invention relates to novel lipopeptide compounds. The invention also relates to pharmaceutical compositions of these compounds and methods of using these compounds as antibacterial compounds. The invention also relates to methods of producing these novel lipopeptide compounds and intermediates used in producing these compounds.
    本发明涉及新型脂肽化合物。本发明还涉及这些化合物的药物组合物以及将这些化合物用作抗菌化合物的方法。本发明还涉及生产这些新型脂肽化合物和用于生产这些化合物的中间体的方法。
  • Pyridonecarboxylic acid derivatives
    申请人:DAIICHI PHARMACEUTICAL CO., LTD.
    公开号:EP0207420B1
    公开(公告)日:1992-05-06
查看更多